Metabolic and Infectious Diseases in La Réunion (the REUNION Population-based Study)
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Blood, DNA, feces, urine, hair and skin microbiota collection.
- Who it may be relevant to
- Registry conditions: Infectious Disease, Cardiovascular Diseases, General Population, Metabolic Disease. Basic parameters: 18 years — 67 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Pathologies métaboliques et Infectieuses en Population générale à La Réunion : étude REUNION
Overview
The aim of the present study is to determine the prevalence of cardiometabolic and infectious disease in La Reunion (french oversea department and region of France). Known or suspected risk factor for these diseases will also be assessed, such as microbiota, cognitive impairement, social inequalities, and genetics.
Detailed description
Overall, 2000 men and women will be recruited during two years for an extensive clinical examination including a microbiota, blood, hair and DNA collection, cognitive tests, autonomous nervous system assessment, spirometry, pulse wave velocity measurement, a carotid doppler echo tracking.
Interventions
- Diagnostic test Blood, DNA, feces, urine, hair and skin microbiota collection
See above
Primary outcome measures
- Prevalence of cardiometabolic diseases [Time frame: cross sectional (at inclusion)]
- Prevalence of infectious diseases [Time frame: cross sectional (at inclusion)]
Eligibility criteria
Inclusion criteria
- 18-67 years
- given consent for genetic analysis,
- written consent for participating in the study
Exclusion criteria
- judicial protection or guardianship
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Centre Hospitalier Universitaire de La Réunion — La Réunion
Identifiers
NCT: NCT05400824 · C19-68 · 2020A0209435